×
Back to Agenda
Session 9: Harnessing AI and Emerging Tech to Transform Pharmacovigilance
Session Chair(s)
Ranjeeta Sinvhal, MD
Executive Medical Director, Medical Safety
AbbVie, United States
Balmeet Gurm, MD
Executive Director, Therapeutic Area Lead Cardiovascular and EBs, Patient Safety
Bristol Myers Squibb, United States
Session 9: Harnessing AI and Emerging Tech to Transform Pharmacovigilance
Speaker(s)
Unlocking Combination Therapy Safety: Integrating Multi-Source Data with Generative AI
Kate Gofman, MD, PhD
AbbVie, United States
Group Medical Director, Innovative Trial Designs, Global Patient Safety
Speaker
Richard Forshee, PhD
FDA, United States
Associate Director of Benefit Risk Assessment, OSE, CDER
Speaker
Michael Forstner, PhD, MPH, MSc
Mesa Laubela-Consulting, Switzerland
Managing Director, Head of Pharmacoepidemiology Practice
Have an account?